{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:03:58Z","timestamp":1784246638315,"version":"3.55.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":64,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16099-8","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:16:32Z","timestamp":1778728592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single-cell and machine learning reveal ROS-associated heterogeneity in hepatocellular carcinoma for precision medicine"],"prefix":"10.1186","volume":"26","author":[{"given":"Xuesong","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoming","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"16099_CR1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13046-021-01912-y","volume":"40","author":"S Kim","year":"2021","unstructured":"Kim S, Lee M, Song Y, Lee SY, Choi I, Park IS, et al. Argininosuccinate synthase 1 suppresses tumor progression through activation of PERK\/eIF2\u03b1\/ATF4\/CHOP axis in hepatocellular carcinoma. J Exp Clin Cancer Res CR. 2021;40:127. https:\/\/doi.org\/10.1186\/s13046-021-01912-y . PubMed PMID: 33838671; PubMed Central PMCID: PMC8035787.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"16099_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.omtn.2021.04.016","volume":"25","author":"M Qin","year":"2021","unstructured":"Qin M, Meng Y, Luo C, He S, Qin F, Yin Y, et al. lncRNA PRR34-AS1 promotes HCC development via modulating Wnt\/\u03b2-catenin pathway by absorbing miR-296-5p and upregulating E2F2 and SOX12. Mol Ther Nucleic Acids. 2021;25:37\u201352. .016 PubMed PMID: 34168917; PubMed Central PMCID: PMC8190132.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"24","key":"16099_CR3","doi-asserted-by":"publisher","first-page":"13627","DOI":"10.3390\/ijms222413627","volume":"22","author":"CI Wang","year":"2021","unstructured":"Wang CI, Chu PM, Chen YL, Lin YH, Chen CY. Chemotherapeutic Drug-Regulated Cytokines Might Influence Therapeutic Efficacy in HCC. Int J Mol Sci. 2021;22(24):13627. https:\/\/doi.org\/10.3390\/ijms222413627 . PubMed PMID: 34948424; PubMed Central PMCID: PMC8707970.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"16099_CR4","first-page":"2993","volume":"10","author":"Z Chen","year":"2020","unstructured":"Chen Z, Xie H, Hu M, Huang T, Hu Y, Sang N, et al. Recent progress in treatment of hepatocellular carcinoma. Am J Cancer Res. 2020;10(9):2993\u20133036. PubMed PMID: 33042631; PubMed Central PMCID: PMC7539784.","journal-title":"Am J Cancer Res"},{"key":"16099_CR5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","volume":"16","author":"S Bagchi","year":"2021","unstructured":"Bagchi S, Yuan R, Engleman EG. Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance. Annu Rev Pathol. 2021;16:223\u201349. https:\/\/doi.org\/10.1146\/annurev-pathol-042020-042741 . PubMed PMID: 33197221.","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"16099_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/14728214.2021.1902503","volume":"26","author":"LL Chan","year":"2021","unstructured":"Chan LL, Chan SL. Emerging immune checkpoint inhibitors for the treatment of hepatocellular carcinoma. Expert Opin Emerg Drugs. 2021;26(1):39\u201352. https:\/\/doi.org\/10.1080\/14728214.2021.1902503 . PubMed PMID: 33724135.","journal-title":"Expert Opin Emerg Drugs"},{"issue":"12","key":"16099_CR7","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41571-020","volume":"17","author":"L Galluzzi","year":"2020","unstructured":"Galluzzi L, Humeau J, Buqu\u00e9 A, Zitvogel L, Kroemer G. Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors. Nat Rev Clin Oncol. 2020;17(12):725\u201341. https:\/\/doi.org\/10.1038\/s41571-020-0413-z. PubMed PMID: 32760014.","journal-title":"Nat Rev Clin Oncol"},{"key":"16099_CR8","doi-asserted-by":"publisher","first-page":"102134","DOI":"10.1016\/j.ctrv.2020.102134","volume":"92","author":"S Hussaini","year":"2021","unstructured":"Hussaini S, Chehade R, Boldt RG, Raphael J, Blanchette P, Maleki Vareki S, et al. Association between immune-related side effects and efficacy and benefit of immune checkpoint inhibitors - A systematic review and meta-analysis. Cancer Treat Rev. 2021;92:102134. https:\/\/doi.org\/10.1016\/j.ctrv.2020.102134 . PubMed PMID: 33302134.","journal-title":"Cancer Treat Rev"},{"key":"16099_CR9","doi-asserted-by":"publisher","first-page":"670391","DOI":"10.3389\/fimmu.2021.670391","volume":"12","author":"M Wang","year":"2021","unstructured":"Wang M, Zhai X, Li J, Guan J, Xu S, Li Y, et al. The Role of Cytokines in Predicting the Response and Adverse Events Related to Immune Checkpoint Inhibitors. Front Immunol. 2021;12:670391. https:\/\/doi.org\/10.3389\/fimmu.2021.670391 . PubMed PMID: 34367136; PubMed Central PMCID: PMC8339552.","journal-title":"Front Immunol"},{"key":"16099_CR10","doi-asserted-by":"publisher","first-page":"843077","DOI":"10.3389\/fimmu.2022.843077","volume":"13","author":"X Qing","year":"2022","unstructured":"Qing X, Xu W, Liu S, Chen Z, Ye C, Zhang Y, Molecular Characteristics. Clinical Significance, and Cancer Immune Interactions of Angiogenesis-Associated Genes in Gastric Cancer. Front Immunol. 2022;13:843077. https:\/\/doi.org\/10.3389\/fimmu.2022.843077 . PubMed PMID: 35273618; PubMed Central PMCID: PMC8901990.","journal-title":"Front Immunol"},{"issue":"2","key":"16099_CR11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1152\/physrev.00008","volume":"101","author":"KF Goliwas","year":"2021","unstructured":"Goliwas KF, Deshane JS, Elmets CA, Athar M. Moving Immune Therapy Forward Targeting TME. Physiol Rev. 2021;101(2):417\u201325. https:\/\/doi.org\/10.1152\/physrev.00008. .2020 PubMed PMID: 32790578; PubMed Central PMCID: PMC8428923.","journal-title":"Physiol Rev"},{"issue":"3","key":"16099_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3109\/08830185.2012.755176","volume":"32","author":"Y Yang","year":"2013","unstructured":"Yang Y, Bazhin AV, Werner J, Karakhanova S. Reactive oxygen species in the immune system. Int Rev Immunol. 2013;32(3):249\u201370. https:\/\/doi.org\/10.3109\/08830185.2012.755176 . PubMed PMID: 23617726.","journal-title":"Int Rev Immunol"},{"issue":"12","key":"16099_CR13","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1002\/jcp.25349","volume":"231","author":"Y Yang","year":"2016","unstructured":"Yang Y, Karakhanova S, Hartwig W, D\u2019Haese JG, Philippov PP, Werner J, et al. Mitochondria and Mitochondrial ROS in Cancer: Novel Targets for Anticancer Therapy. J Cell Physiol. 2016;231(12):2570\u201381. https:\/\/doi.org\/10.1002\/jcp.25349 . PubMed PMID: 26895995.","journal-title":"J Cell Physiol"},{"key":"16099_CR14","first-page":"1","volume":"41","author":"Q Cui","year":"2018","unstructured":"Cui Q, Wang JQ, Assaraf YG, Ren L, Gupta P, Wei L, et al. Modulating ROS to overcome multidrug resistance in cancer. Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother. 2018;41:1\u201325. PubMed PMID: 30471641.","journal-title":"Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother"},{"key":"16099_CR15","doi-asserted-by":"publisher","first-page":"2467940","DOI":"10.1155\/2017\/2467940","volume":"2017","author":"PL de S\u00e1 Junior","year":"2017","unstructured":"de S\u00e1 Junior PL, C\u00e2mara DAD, Porcacchia AS, Fonseca PMM, Jorge SD, Araldi RP, et al. The Roles of ROS in Cancer Heterogeneity and Therapy. Oxid Med Cell Longev. 2017;2017:2467940. https:\/\/doi.org\/10.1155\/2017\/2467940 . PubMed PMID: 29123614; PubMed Central PMCID: PMC5662836.","journal-title":"Oxid Med Cell Longev"},{"issue":"8","key":"16099_CR16","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1089\/ars.2010.3635","volume":"15","author":"O Sareila","year":"2011","unstructured":"Sareila O, Kelkka T, Pizzolla A, Hultqvist M, Holmdahl R. NOX2 complex-derived ROS as immune regulators. Antioxid Redox Signal. 2011;15(8):2197\u2013208. https:\/\/doi.org\/10.1089\/ars.2010.3635 . PubMed PMID: 20919938.","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"16099_CR17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10549-022-06633-0","volume":"194","author":"M Oshi","year":"2022","unstructured":"Oshi M, Gandhi S, Yan L, Tokumaru Y, Wu R, Yamada A, et al. Abundance of reactive oxygen species (ROS) is associated with tumor aggressiveness, immune response, and worse survival in breast cancer. Breast Cancer Res Treat. 2022;194(2):231\u201341. https:\/\/doi.org\/10.1007\/s10549-022-06633-0 . PubMed PMID: 35639264.","journal-title":"Breast Cancer Res Treat"},{"key":"16099_CR18","doi-asserted-by":"publisher","first-page":"4713518","DOI":"10.1155\/2022\/4713518","volume":"2022","author":"Y Xu","year":"2022","unstructured":"Xu Y, He X, Deng J, Xiong L, Chen B, Chen J, et al. ROS-Related miRNAs Regulate Immune Response and Chemoradiotherapy Sensitivity in Hepatocellular Carcinoma by Comprehensive Analysis and Experiment. Oxid Med Cell Longev. 2022;2022:4713518. https:\/\/doi.org\/10.1155\/2022\/4713518 . PubMed PMID: 35585886; PubMed Central PMCID: PMC9110211.","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"16099_CR19","first-page":"88","volume":"18","author":"JM Gostner","year":"2013","unstructured":"Gostner JM, Becker K, Fuchs D, Sucher R. Redox regulation of the immune response. Redox Rep Commun Free Radic Res. 2013;18(3):88\u201394. doi:10.1179\/1351000213Y.0000000044 PubMed PMID: 23601165; PubMed Central PMCID: PMC6837572.","journal-title":"Redox Rep Commun Free Radic Res"},{"key":"16099_CR20","doi-asserted-by":"publisher","first-page":"919083","DOI":"10.3389\/fonc.2022.919083","volume":"12","author":"ZH Ji","year":"2022","unstructured":"Ji ZH, Ren WZ, Wang HQ, Gao W, Yuan B. Molecular Subtyping Based on Cuproptosis-Related Genes and Characterization of Tumor Microenvironment Infiltration in Kidney Renal Clear Cell Carcinoma. Front Oncol. 2022;12:919083. https:\/\/doi.org\/10.3389\/fonc.2022.919083 . PubMed PMID: 35875087; PubMed Central PMCID: PMC9299088.","journal-title":"Front Oncol"},{"key":"16099_CR21","doi-asserted-by":"publisher","unstructured":"Zhang P, Ono A, Fujii Y, Hayes CN, Tamura Y, Miura R, et al. The presence of vessels encapsulating tumor clusters is associated with an immunosuppressive tumor microenvironment in hepatocellular carcinoma. Int J Cancer. 2022 Aug;19. https:\/\/doi.org\/10.1002\/ijc.34247 . PubMed PMID: 36054900.","DOI":"10.1002\/ijc.34247"},{"key":"16099_CR22","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov J, Tamayo P. The Molecular Signatures Database. (MSigDB) hallmark gene set collection - PubMed. Available from: [Cited 2022 Sep 3]. https:\/\/pubmed.ncbi.nlm.nih.gov\/26771021\/"},{"issue":"1","key":"16099_CR23","doi-asserted-by":"publisher","first-page":"360","DOI":"10.7150\/ijbs.66913","volume":"18","author":"D Chen","year":"2022","unstructured":"Chen D, Liu J, Zang L, Xiao T, Zhang X, Li Z, et al. Integrated Machine Learning and Bioinformatic Analyses Constructed a Novel Stemness-Related Classifier to Predict Prognosis and Immunotherapy Responses for Hepatocellular Carcinoma Patients. Int J Biol Sci. 2022;18(1):360\u201373. https:\/\/doi.org\/10.7150\/ijbs.66913 . PubMed PMID: 34975338; PubMed Central PMCID: PMC8692161.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"16099_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12105-015-0617-1","volume":"9","author":"JW Rocco","year":"2015","unstructured":"Rocco JW. Mutant allele tumor heterogeneity (MATH) and head and neck squamous cell carcinoma. Head Neck Pathol. 2015;9(1):1\u20135. https:\/\/doi.org\/10.1007\/s12105-015-0617-1 . PubMed PMID: 25804377; PubMed Central PMCID: PMC4382477.","journal-title":"Head Neck Pathol"},{"key":"16099_CR25","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/1471-2105","volume":"11","author":"R Gaujoux","year":"2010","unstructured":"Gaujoux R, Seoighe C. A flexible R package for nonnegative matrix factorization. BMC Bioinformatics. 2010;11:367. https:\/\/doi.org\/10.1186\/1471-2105. -11-367 PubMed PMID: 20598126; PubMed Central PMCID: PMC2912887.","journal-title":"BMC Bioinformatics"},{"issue":"4","key":"16099_CR26","doi-asserted-by":"publisher","first-page":"109442","DOI":"10.1016\/j.celrep.2021.109442","volume":"36","author":"Y Yang","year":"2021","unstructured":"Yang Y, Sun H, Zhang Y, Zhang T, Gong J, Wei Y, et al. Dimensionality reduction by UMAP reinforces sample heterogeneity analysis in bulk transcriptomic data. Cell Rep. 2021;36(4):109442. https:\/\/doi.org\/10.1016\/j.celrep.2021.109442 . PubMed PMID: 34320340.","journal-title":"Cell Rep"},{"key":"16099_CR27","doi-asserted-by":"publisher","unstructured":"K Y. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4. https:\/\/doi.org\/10.1038\/ncomms3612 . PubMed PMID: 24113773.","DOI":"10.1038\/ncomms3612"},{"key":"16099_CR28","doi-asserted-by":"publisher","first-page":"687975","DOI":"10.3389\/fimmu.2021.687975","volume":"12","author":"D Zeng","year":"2021","unstructured":"Zeng D, Ye Z, Shen R, Yu G, Wu J, Xiong Y, et al. IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures. Front Immunol. 2021;12:687975. https:\/\/doi.org\/10.3389\/fimmu.2021.687975 . PubMed PMID: 34276676; PubMed Central PMCID: PMC8283787.","journal-title":"Front Immunol"},{"issue":"4","key":"16099_CR29","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s00432-024-05731-4","volume":"150","author":"L Wang","year":"2024","unstructured":"Wang L, He Y, Bai Y, Zhang S, Pang B, Chen A, et al. Construction and validation of a folate metabolism-related gene signature for predicting prognosis in HNSCC. J Cancer Res Clin Oncol. 2024;150(4):198. https:\/\/doi.org\/10.1007\/s00432-024-05731-4 . PubMed PMID: 38625586; PubMed Central PMCID: PMC11021263.","journal-title":"J Cancer Res Clin Oncol"},{"key":"16099_CR30","doi-asserted-by":"publisher","unstructured":"Huang H, Cai Y, Hong X, Gao W, Tang J, Zhang S et al. T cell proliferation-related genes: Predicting prognosis, identifying the cold and hot tumors, and guiding treatment in clear cell renal cell carcinoma. Front Genet. 2022;13. Available from: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fgene.2022.948734. [Cited 2022 Sep 3].","DOI":"10.3389\/fgene.2022.948734"},{"issue":"23","key":"16099_CR31","doi-asserted-by":"publisher","first-page":"6575","DOI":"10.1158\/0008-5472.CAN-18-0689","volume":"78","author":"L Xu","year":"2018","unstructured":"Xu L, Deng C, Pang B, Zhang X, Liu W, Liao G, et al. TIP: A Web Server for Resolving Tumor Immunophenotype Profiling. Cancer Res. 2018;78(23):6575\u201380. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-0689 . PubMed PMID: 30154154.","journal-title":"Cancer Res"},{"key":"16099_CR32","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA. gene set variation analysis for microarray and RNA-seq data - PubMed. Available from: [Cited 2023 Mar 14]. https:\/\/pubmed.ncbi.nlm.nih.gov\/23323831\/"},{"issue":"24","key":"16099_CR33","doi-asserted-by":"publisher","first-page":"5357","DOI":"10.1093\/bioinformatics\/btz534","volume":"35","author":"VS Chagas","year":"2019","unstructured":"Chagas VS, Groeneveld CS, Oliveira KG, Trefflich S, de Almeida RC, Ponder BAJ, et al. RTNduals: an R\/Bioconductor package for analysis of co-regulation and inference of dual regulons. Bioinforma Oxf Engl. 2019;35(24):5357\u20138. https:\/\/doi.org\/10.1093\/bioinformatics\/btz534 . PubMed PMID: 31250887; PubMed Central PMCID: PMC6954650.","journal-title":"Bioinforma Oxf Engl"},{"issue":"1","key":"16099_CR34","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.1038\/s41467-023-40457-w","volume":"14","author":"Y Huang","year":"2023","unstructured":"Huang Y, Mohanty V, Dede M, Tsai K, Daher M, Li L, et al. Characterizing cancer metabolism from bulk and single-cell RNA-seq data using METAFlux. Nat Commun. 2023;14(1):4883. https:\/\/doi.org\/10.1038\/s41467-023-40457-w . PubMed PMID: 37573313; PubMed Central PMCID: PMC10423258.","journal-title":"Nat Commun"},{"issue":"1","key":"16099_CR35","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1186\/s12967-025-07223-6","volume":"23","author":"WM Yu","year":"2025","unstructured":"Yu WM, Chen YP, Cheng AL, Zheng ZY, Wang JW, Liu XB, et al. Machine learning-driven prediction models and mechanistic insights into cardiovascular diseases: deciphering the environmental endocrine disruptors nexus. J Transl Med. 2025;23(1):1272. https:\/\/doi.org\/10.1186\/s12967-025-07223-6 . PubMed PMID: 41225610; PubMed Central PMCID: PMC12613883.","journal-title":"J Transl Med"},{"issue":"1","key":"16099_CR36","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1186\/s12967-025-06517-z","volume":"23","author":"Y Hong","year":"2025","unstructured":"Hong Y, Wang D, Liu Z, Chen Y, Wang Y, Li J. Decoding per- and polyfluoroalkyl substances (PFAS) in hepatocellular carcinoma: a multi-omics and computational toxicology approach. J Transl Med. 2025;23(1):504. https:\/\/doi.org\/10.1186\/s12967-025-06517-z . PubMed PMID: 40317014; PubMed Central PMCID: PMC12049027.","journal-title":"J Transl Med"},{"key":"16099_CR37","unstructured":"Qi X, Wang S, Fang C, Jia J, Lin L, Yuan T. Machine learning. and SHAP value interpretation for predicting comorbidity of cardiovascular disease and cancer with dietary antioxidants - PubMed. Available from: [Cited 2026 Feb 4]. https:\/\/pubmed.ncbi.nlm.nih.gov\/39700695\/"},{"issue":"11","key":"16099_CR38","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1111\/cas.16327","volume":"115","author":"S Tang","year":"2024","unstructured":"Tang S, Zhang H, Liang J, Tang S, Li L, Li Y, et al. Prostate cancer treatment recommendation study based on machine learning and SHAP interpreter. Cancer Sci. 2024;115(11):3755\u201366. https:\/\/doi.org\/10.1111\/cas.16327 . PubMed PMID: 39223585; PubMed Central PMCID: PMC11531952.","journal-title":"Cancer Sci"},{"issue":"5","key":"16099_CR39","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018;36(5):411\u201320. https:\/\/doi.org\/10.1038\/nbt.4096 . PubMed PMID: 29608179; PubMed Central PMCID: PMC6700744.","journal-title":"Nat Biotechnol"},{"key":"16099_CR40","doi-asserted-by":"publisher","first-page":"1278496","DOI":"10.3389\/fimmu.2023.1278496","volume":"14","author":"D He","year":"2023","unstructured":"He D, Tang H, Yang X, Liu X, Zhang Y, Shi J. Elaboration and validation of a prognostic signature associated with disulfidoptosis in lung adenocarcinoma, consolidated with integration of single-cell RNA sequencing and bulk RNA sequencing techniques. Front Immunol. 2023;14:1278496. https:\/\/doi.org\/10.3389\/fimmu.2023.1278496 . PubMed PMID: 37965333; PubMed Central PMCID: PMC10641741.","journal-title":"Front Immunol"},{"issue":"10","key":"16099_CR41","doi-asserted-by":"publisher","first-page":"12018","DOI":"10.1002\/cam4","volume":"12","author":"Y Mei","year":"2023","unstructured":"Mei Y, Li M, Wen J, Kong X, Li J. Single-cell characteristics and malignancy regulation of alpha-fetoprotein-producing gastric cancer. Cancer Med. 2023;12(10):12018\u201333. https:\/\/doi.org\/10.1002\/cam4. 5883 PubMed PMID: 37017469; PubMed Central PMCID: PMC10242870.","journal-title":"Cancer Med"},{"issue":"6476","key":"16099_CR42","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1126\/science.aax0249","volume":"367","author":"GS Gulati","year":"2020","unstructured":"Gulati GS, Sikandar SS, Wesche DJ, Manjunath A, Bharadwaj A, Berger MJ, et al. Single-cell transcriptional diversity is a hallmark of developmental potential. Science. 2020;367(6476):405\u201311. https:\/\/doi.org\/10.1126\/science.aax0249 . PubMed PMID: 31974247; PubMed Central PMCID: PMC7694873.","journal-title":"Science"},{"issue":"1","key":"16099_CR43","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, et al. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021;12(1):1088. https:\/\/doi.org\/10.1038\/s41467-021-21246-9 . PubMed PMID: 33597522; PubMed Central PMCID: PMC7889871.","journal-title":"Nat Commun"},{"issue":"10","key":"16099_CR44","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu X, Mao Q, Tang Y, Wang L, Chawla R, Pliner HA, et al. Reversed graph embedding resolves complex single-cell trajectories. Nat Methods. 2017;14(10):979\u201382. https:\/\/doi.org\/10.1038\/nmeth.4402 . PubMed PMID: 28825705; PubMed Central PMCID: PMC5764547.","journal-title":"Nat Methods"},{"issue":"7","key":"16099_CR45","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1038\/s41596-020-0336-2","volume":"15","author":"B Van de Sande","year":"2020","unstructured":"Van de Sande B, Flerin C, Davie K, De Waegeneer M, Hulselmans G, Aibar S, et al. A scalable SCENIC workflow for single-cell gene regulatory network analysis. Nat Protoc. 2020;15(7):2247\u201376. https:\/\/doi.org\/10.1038\/s41596-020-0336-2 . PubMed PMID: 32561888.","journal-title":"Nat Protoc"},{"issue":"8","key":"16099_CR46","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1158\/0008-5472.CAN-23-2650","volume":"84","author":"J Shi","year":"2024","unstructured":"Shi J, Wei X, Xun Z, Ding X, Liu Y, Liu L, et al. The Web-Based Portal SpatialTME Integrates Histological Images with Single-Cell and Spatial Transcriptomics to Explore the Tumor Microenvironment. Cancer Res. 2024;84(8):1210\u201320. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-2650 . PubMed PMID: 38315776.","journal-title":"Cancer Res"},{"issue":"6","key":"16099_CR47","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.ccell.2017.05.010","volume":"31","author":"G Abril-Rodriguez","year":"2017","unstructured":"Abril-Rodriguez G, Ribas A, SnapShot. Immune Checkpoint Inhibitors. Cancer Cell. 2017;31(6):848\u2013e8481. https:\/\/doi.org\/10.1016\/j.ccell.2017.05.010 . PubMed PMID: 28609660.","journal-title":"Cancer Cell"},{"issue":"6","key":"16099_CR48","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s00262-021-03076-2","volume":"71","author":"JN Guo","year":"2022","unstructured":"Guo JN, Chen D, Deng SH, Huang JR, Song JX, Li XY, et al. Identification and quantification of immune infiltration landscape on therapy and prognosis in left- and right-sided colon cancer. Cancer Immunol Immunother. 2022;71(6):1313\u201330. https:\/\/doi.org\/10.1007\/s00262-021-03076-2 . PubMed PMID: 34657172; PubMed Central PMCID: PMC9122887.","journal-title":"Cancer Immunol Immunother"},{"issue":"6349","key":"16099_CR49","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","volume":"357","author":"DT Le","year":"2017","unstructured":"Le DT, Durham JN, Smith KN, Wang H, Bartlett BR, Aulakh LK, et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science. 2017;357(6349):409\u201313. https:\/\/doi.org\/10.1126\/science.aan6733 . PubMed PMID: 28596308; PubMed Central PMCID: PMC5576142.","journal-title":"Science"},{"issue":"Database issue","key":"16099_CR50","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gks1111","volume":"41","author":"W Yang","year":"2013","unstructured":"Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H, Forbes S, et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2013;41(Database issue):D955\u2013961. https:\/\/doi.org\/10.1093\/nar\/gks1111 . PubMed PMID: 23180760; PubMed Central PMCID: PMC3531057.","journal-title":"Nucleic Acids Res"},{"issue":"1\u20132","key":"16099_CR51","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.drup.2012.01.003","volume":"15","author":"O Lavi","year":"2012","unstructured":"Lavi O, Gottesman MM, Levy D. The dynamics of drug resistance: a mathematical perspective. Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother. 2012;15(1\u20132):90\u20137. https:\/\/doi.org\/10.1016\/j.drup.2012.01.003 . PubMed PMID: 22387162; PubMed Central PMCID: PMC3348255.","journal-title":"Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother"},{"key":"16099_CR52","doi-asserted-by":"publisher","first-page":"102227","DOI":"10.1016\/j.ctrv.2021.102227","volume":"101","author":"CL Gerard","year":"2021","unstructured":"Gerard CL, Delyon J, Wicky A, Homicsko K, Cuendet MA, Michielin O. Turning tumors from cold to inflamed to improve immunotherapy response. Cancer Treat Rev. 2021;101:102227. https:\/\/doi.org\/10.1016\/j.ctrv.2021.102227 . PubMed PMID: 34656019.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"16099_CR53","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D, et al. Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade. Cell Rep. 2017;18(1):248\u201362. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.019 . PubMed PMID: 28052254.","journal-title":"Cell Rep"},{"issue":"5","key":"16099_CR54","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1053\/j.gastro.2023","volume":"164","author":"MR Toh","year":"2023","unstructured":"Toh MR, Wong EYT, Wong SH, Ng AWT, Loo LH, Chow PKH, et al. Global Epidemiology and Genetics of Hepatocellular Carcinoma. Gastroenterology. 2023;164(5):766\u201382. https:\/\/doi.org\/10.1053\/j.gastro.2023. 01.033 PubMed PMID: 36738977.","journal-title":"Gastroenterology"},{"issue":"2","key":"16099_CR55","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/bib\/bby026","volume":"20","author":"L Zhao","year":"2019","unstructured":"Zhao L, Lee VHF, Ng MK, Yan H, Bijlsma MF. Molecular subtyping of cancer: current status and moving toward clinical applications. Brief Bioinform. 2019;20(2):572\u201384. https:\/\/doi.org\/10.1093\/bib\/bby026 . PubMed PMID: 29659698.","journal-title":"Brief Bioinform"},{"issue":"4","key":"16099_CR56","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41575-019-0109","volume":"16","author":"EA Collisson","year":"2019","unstructured":"Collisson EA, Bailey P, Chang DK, Biankin AV. Molecular subtypes of pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2019;16(4):207\u201320. https:\/\/doi.org\/10.1038\/s41575-019-0109. -y PubMed PMID: 30718832.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"16099_CR57","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1158\/1078-0432.CCR-18-3241","volume":"25","author":"A Talhouk","year":"2019","unstructured":"Talhouk A, Derocher H, Schmidt P, Leung S, Milne K, Gilks CB, et al. Molecular Subtype Not Immune Response Drives Outcomes in Endometrial Carcinoma. Clin Cancer Res Off J Am Assoc Cancer Res. 2019;25(8):2537\u201348. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-3241 . PubMed PMID: 30523022.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"1","key":"16099_CR58","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/jnci\/dju357","volume":"107","author":"ER Paquet","year":"2015","unstructured":"Paquet ER, Hallett MT. Absolute assignment of breast cancer intrinsic molecular subtype. J Natl Cancer Inst. 2015;107(1):357. https:\/\/doi.org\/10.1093\/jnci\/dju357 . PubMed PMID: 25479802.","journal-title":"J Natl Cancer Inst"},{"key":"16099_CR59","doi-asserted-by":"publisher","first-page":"101084","DOI":"10.1016\/j.redox","volume":"25","author":"US Srinivas","year":"2019","unstructured":"Srinivas US, Tan BWQ, Vellayappan BA, Jeyasekharan AD. ROS and the DNA damage response in cancer. Redox Biol. 2019;25:101084. https:\/\/doi.org\/10.1016\/j.redox. .2018.101084 PubMed PMID: 30612957; PubMed Central PMCID: PMC6859528.","journal-title":"Redox Biol"},{"issue":"1","key":"16099_CR60","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.arr.2012.10.004","volume":"12","author":"V Sosa","year":"2013","unstructured":"Sosa V, Molin\u00e9 T, Somoza R, Paciucci R, Kondoh H, LLeonart ME. Oxidative stress and cancer: an overview. Ageing Res Rev. 2013;12(1):376\u201390. https:\/\/doi.org\/10.1016\/j.arr.2012.10.004 . PubMed PMID: 23123177.","journal-title":"Ageing Res Rev"},{"issue":"10","key":"16099_CR61","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.7150\/thno.56747","volume":"11","author":"Y Wang","year":"2021","unstructured":"Wang Y, Qi H, Liu Y, Duan C, Liu X, Xia T, et al. The double-edged roles of ROS in cancer prevention and therapy. Theranostics. 2021;11(10):4839\u201357. https:\/\/doi.org\/10.7150\/thno.56747 . PubMed PMID: 33754031; PubMed Central PMCID: PMC7978298.","journal-title":"Theranostics"},{"key":"16099_CR62","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.canlet.2016.03","volume":"387","author":"S Prasad","year":"2017","unstructured":"Prasad S, Gupta SC, Tyagi AK. Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticals. Cancer Lett. 2017;387:95\u2013105. https:\/\/doi.org\/10.1016\/j.canlet.2016.03. .042 PubMed PMID: 27037062.","journal-title":"Cancer Lett"},{"issue":"7","key":"16099_CR63","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrd2803","volume":"8","author":"D Trachootham","year":"2009","unstructured":"Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. 2009;8(7):579\u201391. https:\/\/doi.org\/10.1038\/nrd2803 . PubMed PMID: 19478820.","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"16099_CR64","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","volume":"22","author":"EC Cheung","year":"2022","unstructured":"Cheung EC, Vousden KH. The role of ROS in tumour development and progression. Nat Rev Cancer. 2022;22(5):280\u201397. https:\/\/doi.org\/10.1038\/s41568-021-00435-0 . PubMed PMID: 35102280.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"16099_CR65","doi-asserted-by":"publisher","first-page":"E735","DOI":"10.3390\/biom9110735","volume":"9","author":"V Aggarwal","year":"2019","unstructured":"Aggarwal V, Tuli HS, Varol A, Thakral F, Yerer MB, Sak K, et al. Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements. Biomolecules. 2019;9(11):E735. https:\/\/doi.org\/10.3390\/biom9110735 . PubMed PMID: 31766246; PubMed Central PMCID: PMC6920770.","journal-title":"Biomolecules"},{"issue":"12","key":"16099_CR66","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nrd4002","volume":"12","author":"C Gorrini","year":"2013","unstructured":"Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013;12(12):931\u201347. https:\/\/doi.org\/10.1038\/nrd4002 . PubMed PMID: 24287781.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"16099_CR67","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.drup.2004","volume":"7","author":"H Pelicano","year":"2004","unstructured":"Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother. 2004;7(2):97\u2013110. https:\/\/doi.org\/10.1016\/j.drup.2004. 01.004 PubMed PMID: 15158766.","journal-title":"Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother"},{"key":"16099_CR68","doi-asserted-by":"publisher","unstructured":"Xu J, Ji L, Ruan Y, Wan Z, Lin Z, Xia S, et al. UBQLN1 mediates sorafenib resistance through regulating mitochondrial biogenesis and ROS homeostasis by targeting PGC1\u03b2 in hepatocellular carcinoma. Signal Transduct Target Ther. 2021;6. https:\/\/doi.org\/10.1038\/s41392-021-00594-4 . PubMed PMID: 34001851.","DOI":"10.1038\/s41392-021-00594-4"},{"key":"16099_CR69","doi-asserted-by":"publisher","first-page":"22731","DOI":"10.1002\/adfm.202522731","volume":"36","author":"Wang Jiawen","year":"2026","unstructured":"Wang JW, Wang JF, Wang Z, Wu JY, Liao JX, Zhan SY, et al. Piezocatalytic Pt@BMO-Gel Dressing for In Situ Generation of H2 and NO to Treat Infectious Inflammation Related to Incontinence. Adv Funct Mater. 2026;36(25):e22731. https:\/\/doi.org\/10.1002\/adfm.202522731.","journal-title":"Adv Funct Mater"},{"issue":"4","key":"16099_CR70","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.tcb.2015.12","volume":"26","author":"H Blaser","year":"2016","unstructured":"Blaser H, Dostert C, Mak TW, Brenner D. TNF and ROS Crosstalk in Inflammation. Trends Cell Biol. 2016;26(4):249\u201361. https:\/\/doi.org\/10.1016\/j.tcb.2015.12. .002 PubMed PMID: 26791157.","journal-title":"Trends Cell Biol"},{"key":"16099_CR71","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.3389\/fimmu","volume":"9","author":"K Ohl","year":"2018","unstructured":"Ohl K, Tenbrock K. Reactive Oxygen Species as Regulators of MDSC-Mediated Immune Suppression. Front Immunol. 2018;9:2499. https:\/\/doi.org\/10.3389\/fimmu. .2018.02499 PubMed PMID: 30425715; PubMed Central PMCID: PMC6218613.","journal-title":"Front Immunol"},{"issue":"18","key":"16099_CR72","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472","volume":"79","author":"DC Hinshaw","year":"2019","unstructured":"Hinshaw DC, Shevde LA. The Tumor Microenvironment Innately Modulates Cancer Progression. Cancer Res. 2019;79(18):4557\u201366. https:\/\/doi.org\/10.1158\/0008-5472. .CAN-18-3962 PubMed PMID: 31350295; PubMed Central PMCID: PMC6744958.","journal-title":"Cancer Res"},{"key":"16099_CR73","doi-asserted-by":"publisher","first-page":"42","DOI":"10.20517\/cdr.2025.124","volume":"8","author":"C Fang","year":"2025","unstructured":"Fang C, Zhang Q, Fang R, Li Y, Bai J, Huang X, et al. ROS1 mutations promote an immunosuppressive tumor microenvironment via MYC to confer immune evasion in head and neck cancer. Cancer Drug Resist. 2025;8:42. https:\/\/doi.org\/10.20517\/cdr.2025.124 . PubMed PMID: 40873541; PubMed Central PMCID: PMC12378350.","journal-title":"Cancer Drug Resist"},{"key":"16099_CR74","doi-asserted-by":"publisher","first-page":"843515","DOI":"10.3389\/fimmu.2022.843515","volume":"13","author":"Y Tang","year":"2022","unstructured":"Tang Y, Tian W, Xie J, Zou Y, Wang Z, Li N, et al. Prognosis and Dissection of Immunosuppressive Microenvironment in Breast Cancer Based on Fatty Acid Metabolism-Related Signature. Front Immunol. 2022;13:843515. https:\/\/doi.org\/10.3389\/fimmu.2022.843515 . PubMed PMID: 35432381; PubMed Central PMCID: PMC9009264.","journal-title":"Front Immunol"},{"issue":"2","key":"16099_CR75","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.canlet.2015","volume":"379","author":"L Li","year":"2016","unstructured":"Li L, Wang H. Heterogeneity of liver cancer and personalized therapy. Cancer Lett. 2016;379(2):191\u20137. https:\/\/doi.org\/10.1016\/j.canlet.2015. 07.018 PubMed PMID: 26213370.","journal-title":"Cancer Lett"},{"issue":"2","key":"16099_CR76","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jhep.2009","volume":"52","author":"TA Dragani","year":"2010","unstructured":"Dragani TA. Risk of HCC: genetic heterogeneity and complex genetics. J Hepatol. 2010;52(2):252\u20137. https:\/\/doi.org\/10.1016\/j.jhep.2009. 11.015 PubMed PMID: 20022654.","journal-title":"J Hepatol"},{"key":"16099_CR77","doi-asserted-by":"publisher","first-page":"1688699","DOI":"10.3389\/fimmu.2025.1688699","volume":"16","author":"X Wang","year":"2025","unstructured":"Wang X, He J, Ding G, Tang Y, Wang Q. Overcoming resistance to PD-1 and CTLA-4 blockade mechanisms and therapeutic strategies. Front Immunol. 2025;16:1688699. https:\/\/doi.org\/10.3389\/fimmu.2025.1688699 . PubMed PMID: 41112253; PubMed Central PMCID: PMC12531160.","journal-title":"Front Immunol"},{"issue":"8038","key":"16099_CR78","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41586-024-07943-7","volume":"635","author":"F Skoulidis","year":"2024","unstructured":"Skoulidis F, Araujo HA, Do MT, Qian Y, Sun X, Galan-Cobo A, et al. CTLA4 blockade abrogates KEAP1\/STK11-related resistance to PD-(L)1 inhibitors. Nature. 2024;635(8038):462\u201371. https:\/\/doi.org\/10.1038\/s41586-024-07943-7.","journal-title":"Nature"},{"key":"16099_CR79","doi-asserted-by":"publisher","first-page":"101179","DOI":"10.1016\/j.drup.2024.101179","volume":"78","author":"Y Chen","year":"2025","unstructured":"Chen Y, Mi Y, Tan S, Chen Y, Liu S, Lin S, et al. CEA-induced PI3K\/AKT pathway activation through the binding of CEA to KRT1 contributes to oxaliplatin resistance in gastric cancer. Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother. 2025;78:101179. https:\/\/doi.org\/10.1016\/j.drup.2024.101179 . PubMed PMID: 39644827.","journal-title":"Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother"},{"issue":"7","key":"16099_CR80","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3390\/pharmaceutics17070886","volume":"17","author":"YY Fan","year":"2025","unstructured":"Fan YY, Wu H, Xu C. ROS-Responsive Nanoplatforms for Targeted Tumor Immunomodulation: A Paradigm Shift in Precision Cancer Immunotherapy. Pharmaceutics. 2025;17(7):886. https:\/\/doi.org\/10.3390\/pharmaceutics17070886 . PubMed PMID: 40733095; PubMed Central PMCID: PMC12299577.","journal-title":"Pharmaceutics"},{"issue":"3","key":"16099_CR81","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1159\/000367739","volume":"4","author":"M Tsurusaki","year":"2015","unstructured":"Tsurusaki M, Murakami T, Surgical, Locoregional Therapy of HCC: TACE. Liver Cancer. 2015;4(3):165\u201375. doi:10.1159\/000367739 PubMed PMID: 26675172; PubMed Central PMCID: PMC4608659.","journal-title":"Liver Cancer"},{"issue":"1","key":"16099_CR82","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","volume":"5","author":"W Tang","year":"2020","unstructured":"Tang W, Chen Z, Zhang W, Cheng Y, Zhang B, Wu F, et al. The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects. Signal Transduct Target Ther. 2020;5(1):87. https:\/\/doi.org\/10.1038\/s41392-020-0187-x . PubMed PMID: 32532960; PubMed Central PMCID: PMC7292831.","journal-title":"Signal Transduct Target Ther"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16099-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16099-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16099-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T23:16:47Z","timestamp":1784243807000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16099-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16099"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16099-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"857"}}